Carolina Magdalen Greco

Carolina Magdalen Greco

Auto-generated profile, based on publicly available information

Carolina Magdalen Greco

Department of Biomedical Sciences, Humanitas University, Milan, Italy (C.M.G.).

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Cell
Verified
Journal Article
Closed access
Eduardo BonavitaEduardo Bonavita
Eduardo Bonavita
SGStefania Gentile
Stefania Gentile
MRMarcello Rubino
Marcello Rubino
VMVirginia Maina
Virginia Maina
RPRoberto Papait
Roberto Papait
Alberto MantovaniAlberto Mantovani
Alberto Mantovani

27 November 2013 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
RPRoberto Papait
Roberto Papait
PCPaola Cattaneo
Paola Cattaneo
PKPaolo Kunderfranco
Paolo Kunderfranco
CGCarolina Greco
Carolina Greco
PCPierluigi Carullo
Pierluigi Carullo
Gerolama CondorelliGerolama Condorelli
Gerolama Condorelli
Significance: Cardiac failure is a leading cause of mortality worldwide and a major financial burden for healthcare systems. New tools for understanding cardiovascular disease and developing better therapeutic approaches are therefore needed. To this end, transcriptional regulation has been extensively studied in cardiac hypertrophy and failure, but there is still a lack of understanding of the epigenetic framework in which transcription factors act. Our report adds significant knowledge to the field because we demonstrate, in vivo, that a complex and specific epigenetic signature regulates gene expression by modulating promoters and enhancers, a large number of which have been described here. These findings advance our understanding of the mechanisms underlying this pathology.

6 March 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
MKMarinos Kallikourdis
Marinos Kallikourdis
EMElisa Martini
Elisa Martini
PCPierluigi Carullo
Pierluigi Carullo
CSClaudia Sardi
Claudia Sardi
GRGiuliana Roselli
Giuliana Roselli
Gerolama CondorelliGerolama Condorelli
Gerolama Condorelli
Heart failure (HF) is a leading cause of mortality. Inflammation is implicated in HF, yet clinical trials targeting pro-inflammatory cytokines in HF were unsuccessful, possibly due to redundant functions of individual cytokines. Searching for better cardiac inflammation targets, here we link T cells with HF development in a mouse model of pathological cardiac hypertrophy and in human HF patients. T cell costimulation blockade, through FDA-approved rheumatoid arthritis drug abatacept, leads to highly significant delay in progression and decreased severity of cardiac dysfunction in the mouse HF model. The therapeutic effect occurs via inhibition of activation and cardiac infiltration of T cells and macrophages, leading to reduced cardiomyocyte death. Abatacept treatment also induces production of anti-inflammatory cytokine interleukin-10 (IL-10). IL-10-deficient mice are refractive to treatment, while protection could be rescued by transfer of IL-10-sufficient B cells. These results suggest that T cell costimulation blockade might be therapeutically exploited to treat HF.

4 August 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
CGCarolina M. Greco
Carolina M. Greco
PKPaolo Kunderfranco
Paolo Kunderfranco
MRMarcello Rubino
Marcello Rubino
VLVeronica Larcher
Veronica Larcher
PCPierluigi Carullo
Pierluigi Carullo
Gerolama CondorelliGerolama Condorelli
Gerolama Condorelli
Methylation at 5-cytosine (5-mC) is a fundamental epigenetic DNA modification associated recently with cardiac disease. In contrast, the role of 5-hydroxymethylcytosine (5-hmC)—5-mC’s oxidation product—in cardiac biology and disease is unknown. Here we assess the hydroxymethylome in embryonic, neonatal, adult and hypertrophic mouse cardiomyocytes, showing that dynamic modulation of hydroxymethylated DNA is associated with specific transcriptional networks during heart development and failure. DNA hydroxymethylation marks the body of highly expressed genes as well as distal regulatory regions with enhanced activity. Moreover, pathological hypertrophy is characterized by a shift towards a neonatal 5-hmC distribution pattern. We also show that the ten-eleven translocation 2 (TET2) enzyme regulates the expression of key cardiac genes, such as Myh7, through 5-hmC deposition on the gene body and at enhancers. Thus, we provide a genome-wide analysis of 5-hmC in the cardiomyocyte and suggest a role for this epigenetic modification in heart development and disease.

12 May 2015 in Nature Reviews Cardiology
Verified
Journal Article
Closed access
PDF file
CGCarolina M. Greco
Carolina M. Greco
Gerolama CondorelliGerolama Condorelli
Gerolama Condorelli

1 August 2021 in Cell Reports
Verified
Journal Article
Open access
KKKevin B. Koronowski
Kevin B. Koronowski
CGCarolina M. Greco
Carolina M. Greco
HHHe Huang
He Huang
JKJin-Kwang Kim
Jin-Kwang Kim
JFJennifer L. Fribourgh
Jennifer L. Fribourgh
PSPaolo Sassone-Corsi
Paolo Sassone-Corsi
Ketone bodies are bioactive metabolites that function as energy substrates, signaling molecules, and regulators of histone modifications. β-hydroxybutyrate (β-OHB) is utilized in lysine β-hydroxybutyrylation (Kbhb) of histones, and associates with starvation-responsive genes, effectively coupling ketogenic metabolism with gene expression. The emerging diversity of the lysine acylation landscape prompted us to investigate the full proteomic impact of Kbhb. Global protein Kbhb is induced in a tissue-specific manner by a variety of interventions that evoke β-OHB. Mass spectrometry analysis of the β-hydroxybutyrylome in mouse liver revealed 891 sites of Kbhb within 267 proteins enriched for fatty acid, amino acid, detoxification, and one-carbon metabolic pathways. Kbhb inhibits S-adenosyl-L-homocysteine hydrolase (AHCY), a rate-limiting enzyme of the methionine cycle, in parallel with altered metabolite levels. Our results illuminate the role of Kbhb in hepatic metabolism under ketogenic conditions and demonstrate a functional consequence of this modification on a central metabolic enzyme.